Stay updated on DUR-928 Alcoholic Hepatitis Clinical Trial
Sign up to get notified when there's something new on the DUR-928 Alcoholic Hepatitis Clinical Trial page.

Latest updates to the DUR-928 Alcoholic Hepatitis Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a minor update to the study record on ClinicalTrials.gov.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page’s revision/version tag was updated from **v3.5.0** to **v3.5.3**, indicating a minor technical site release without altering the clinical trial content.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 across the page. No changes to the study details, eligibility criteria, or outcome measures.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. No user-facing content or study details were modified.SummaryDifference0.0%

- Check96 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2; no study content or critical information appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check103 days agoChange DetectedAdded NEJM Evid. publication citation for Larsucosterol in Alcoholic Hepatitis and updated to revision v3.4.1; removed the Erratum entry for that article in Publications.SummaryDifference0.1%

Stay in the know with updates to DUR-928 Alcoholic Hepatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DUR-928 Alcoholic Hepatitis Clinical Trial page.